A variety of dermatoses have been reported in the growing number of patients treated with immune checkpoint inhibitors (ICIs), but the current understanding of cutaneous immune related adverse events (irAEs) […]
A variety of dermatoses have been reported in the growing number of patients treated with immune checkpoint inhibitors (ICIs), but the current understanding of cutaneous immune related adverse events (irAEs) […]